Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Autoimmune hemolytic anemia screening
Introduction
Overview
Overview
Screening for autoimmune hemolytic anemia is not currently done routinely.
Screening
Screening
- Screening for autoimmune hemolytic anemia is not currently done routinely.
- The incidence of autoimmune hemolytic anemia is low enough such that screening measures are not indicated.
- However, screening is done for other conditions associated with hemolytic anemia, such as sickle cell disease.[1]
- One important manifestation of sickle cell disease is hyperhemolytic crisis, in which there is massive hemolysis.
- The United States and the United Kingdom have formal screening processes in place for sickle cell disease for newborns.
- Screening for sickle cell disease can prevent early childhood morbidity and mortality.
- Less developed countries, such as countries in Africa, do not have formal screening measures for sickle cell disease in place.[1]
References
References
- ↑ 1.0 1.1 Alapan Y, Fraiwan A, Kucukal E, Hasan MN, Ung R, Kim M; et al. (2016). “Emerging point-of-care technologies for sickle cell disease screening and monitoring”. Expert Rev Med Devices. 13 (12): 1073–1093. doi:10.1080/17434440.2016.1254038. PMC 5166583. PMID 27785945.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shyam Patel [2], Irfan Dotani [3]